Interleukin-2 (IL-2) is a well-known cytokine that plays a crucial role in stimulating immune cells, including natural killer (NK) cells and cytotoxic T cells. It has been studied as an immunotherapy ...

occurring after a minimum of 90 days and within 2 years of treatment initiation. Sensitivity analyses used 1:1 propensity ...

This page includes links to articles highlighting the top skin cancer research published on Cancer Therapy Advisor in 2024.

A U.S. health panel says women should have the option of taking their own test samples for cervical cancer screening. The ...

Vitale had surgery in the summer to remove cancerous lymph nodes from his neck. He was previously treated for melanoma and ...

Nektar and Bristol-Myers Squibb also have a pegylated IL-2 drug heading for a phase 3 readout, but that candidate – bempegaldesleukin (NKTR-214) – is being developed as a cancer therapy.

Based on more than six months of additional monitoring, data show continued improvement in overall survival (OS) in intent-to-treat (ITT) ...

Nov. 11, 2024 — Researchers have discovered a new way in which RAS genes, which are commonly mutated in cancer, may drive tumor growth beyond their well-known role in signaling at the cell surface.

Dick Vitale said he’s cancer-free after his fourth bout with the disease in just over three years. The 85-year-old ESPN college basketball analyst announced Thursday on social media that he ...

Sandberg is a graduate from North Central High School and played most of his career with the Chicago Cubs and was inducted ...

Clinical Cancer Research publishes articles that focus on innovative clinical and translational research bridging the laboratory and the clinic. Topics include targeted therapies; mechanisms of drug ...